GeneSys is a next-generation diagnostic platform that stands at the intersection of molecular biology, artificial intelligence, and decentralized healthcare. Its unique combination of a lab-grade, AI-enhanced diagnostic engine with a portable, cost-effective, and user-friendly platform addresses the critical market gap that has fueled the antimicrobial resistance (AMR) crisis for decades. The platform's ability to provide a 30-minute, dual-profile diagnosis of pathogens and their resistance genes in a single run is a transformative capability with a tangible, quantifiable impact on patient outcomes and healthcare economics.
| Website | https://genesysbio.com/ |
| Employees | 5 (1 on RocketReach) |
| Founded | 2023 |
| Industry | Biotechnology Research |
| Keywords | Pathogen Detection, Rapid Diagnostics, Diagnostic Testing, Diagnostic Technology, Clinical Diagnostics, Biosensors, Molecular Diagnostics, Point Of Care Diagnostics, Diagnostic Tools, Infectious Disease, Medical Devices, Healthcare Technology, Disease Surveillance, Biotechnology, Human Health, Life Sciences, Immunoassay, Public Health, Environmental Monitoring, Animal Health |
Looking for a particular GeneSys Bio employee's phone or email?
Eros Venturini is the Amministratore delegato of GeneSys Bio.
1 people are employed at GeneSys Bio.